Aspen Pharmacare Holdings Ltd (APN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aspen Pharmacare Holdings Ltd (APN) has a cash flow conversion efficiency ratio of 0.044x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ZAC3.58 Billion ≈ $1.90 Million USD) by net assets (ZAC81.09 Billion ≈ $43.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Aspen Pharmacare Holdings Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Aspen Pharmacare Holdings Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Aspen Pharmacare Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Aspen Pharmacare Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aspen Pharmacare Holdings Ltd ranked by their cash flow conversion efficiency. Explore Aspen Pharmacare Holdings Ltd (APN) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DMG MORI AKTIENGESELLSCHAFT
XETRA:GIL
|
0.012x |
|
Unifirst Corporation
NYSE:UNF
|
0.023x |
|
Tangshan Port Group Co Ltd
SHG:601000
|
0.028x |
|
S N Nuclearele
RO:SNN
|
0.054x |
|
USA Compression Partners LP
NYSE:USAC
|
0.507x |
|
Otter Tail Corporation
NASDAQ:OTTR
|
0.060x |
|
Doosan Bobcat Inc
KO:241560
|
0.001x |
|
Sigurd Microelectronics Corp
TW:6257
|
0.074x |
Annual Cash Flow Conversion Efficiency for Aspen Pharmacare Holdings Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Aspen Pharmacare Holdings Ltd from 2003 to 2025. View APN live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | ZAC84.89 Billion ≈ $45.12 Million |
ZAC5.16 Billion ≈ $2.74 Million |
0.061x | -17.16% |
| 2024-06-30 | ZAC84.86 Billion ≈ $45.10 Million |
ZAC6.22 Billion ≈ $3.31 Million |
0.073x | +14.60% |
| 2023-06-30 | ZAC86.24 Billion ≈ $45.83 Million |
ZAC5.52 Billion ≈ $2.93 Million |
0.064x | -15.50% |
| 2022-06-30 | ZAC70.94 Billion ≈ $37.70 Million |
ZAC5.37 Billion ≈ $2.86 Million |
0.076x | -27.16% |
| 2021-06-30 | ZAC65.63 Billion ≈ $34.88 Million |
ZAC6.83 Billion ≈ $3.63 Million |
0.104x | -12.85% |
| 2020-06-30 | ZAC69.22 Billion ≈ $36.79 Million |
ZAC8.26 Billion ≈ $4.39 Million |
0.119x | +7.79% |
| 2019-06-30 | ZAC54.21 Billion ≈ $28.81 Million |
ZAC6.00 Billion ≈ $3.19 Million |
0.111x | -20.96% |
| 2018-06-30 | ZAC50.09 Billion ≈ $26.62 Million |
ZAC7.02 Billion ≈ $3.73 Million |
0.140x | -7.12% |
| 2017-06-30 | ZAC43.10 Billion ≈ $22.91 Million |
ZAC6.50 Billion ≈ $3.45 Million |
0.151x | +100.30% |
| 2016-06-30 | ZAC42.50 Billion ≈ $22.59 Million |
ZAC3.20 Billion ≈ $1.70 Million |
0.075x | -46.84% |
| 2015-06-30 | ZAC34.16 Billion ≈ $18.16 Million |
ZAC4.84 Billion ≈ $2.57 Million |
0.142x | +6.62% |
| 2014-06-30 | ZAC28.88 Billion ≈ $15.35 Million |
ZAC3.84 Billion ≈ $2.04 Million |
0.133x | -24.01% |
| 2013-06-30 | ZAC22.80 Billion ≈ $12.12 Million |
ZAC3.99 Billion ≈ $2.12 Million |
0.175x | +4.59% |
| 2012-06-30 | ZAC17.40 Billion ≈ $9.25 Million |
ZAC2.91 Billion ≈ $1.55 Million |
0.167x | -9.19% |
| 2011-06-30 | ZAC13.29 Billion ≈ $7.06 Million |
ZAC2.45 Billion ≈ $1.30 Million |
0.184x | -1.43% |
| 2010-06-30 | ZAC10.89 Billion ≈ $5.79 Million |
ZAC2.03 Billion ≈ $1.08 Million |
0.187x | -38.39% |
| 2009-06-30 | ZAC4.26 Billion ≈ $2.27 Million |
ZAC1.29 Billion ≈ $686.68K |
0.303x | +54.19% |
| 2008-06-30 | ZAC3.32 Billion ≈ $1.76 Million |
ZAC652.38 Million ≈ $346.71K |
0.197x | -33.71% |
| 2007-06-30 | ZAC2.39 Billion ≈ $1.27 Million |
ZAC708.56 Million ≈ $376.56K |
0.297x | +27.24% |
| 2006-06-30 | ZAC1.73 Billion ≈ $917.16K |
ZAC402.21 Million ≈ $213.76K |
0.233x | -59.58% |
| 2005-06-30 | ZAC1.11 Billion ≈ $588.19K |
ZAC638.20 Million ≈ $339.17K |
0.577x | +23.31% |
| 2004-06-30 | ZAC1.07 Billion ≈ $566.78K |
ZAC498.74 Million ≈ $265.05K |
0.468x | -3.67% |
| 2003-06-30 | ZAC794.98 Million ≈ $422.49K |
ZAC385.95 Million ≈ $205.11K |
0.485x | -- |
About Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic ag… Read more